Best HER2/neu Receptor Antagonist for breast neoplasms
2 HER2/neu Receptor Antagonist drugs indicated for breast neoplasms, ranked by our independent rating. The current highest-rated is herceptin. Compare them with all treatments for breast neoplasms or the full HER2/neu Receptor Antagonist class. Not medical advice — always consult a professional.
Top her2/neu receptor antagonist for breast neoplasms: 1. Herceptin · 2. Hercessi
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Herceptin | 72/100 | Prescription | — | View → |
| 2 | Hercessi | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best her2/neu receptor antagonist for breast neoplasms?
- By our independent rating, herceptin currently ranks highest among HER2/neu Receptor Antagonist drugs used for breast neoplasms. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which her2/neu receptor antagonist drugs treat breast neoplasms?
- pharmaranks lists 2 HER2/neu Receptor Antagonist products indicated for breast neoplasms, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.